[Clinical implications of bisphosphonate for bone metastases of prostate cancer]

Nihon Rinsho. 2007 Nov 28:65 Suppl 9:356-9.

[Article in Japanese]

Authors

Yasuhide Kitagawa¹, Hiroyuki Konaka, Atsushi Mizokami, Mikio Namiki

Affiliation

¹ Department of Urology, School of Medicine, Kanazawa University.

PMID: 18161131

No abstract available

Publication types

Review

MeSH terms

Bone Density Conservation Agents / pharmacology
Bone Density Conservation Agents / therapeutic use*
Bone Neoplasms / etiology
Bone Neoplasms / prevention & control
Bone Neoplasms / secondary*
Bone Resorption / prevention & control
Diphosphonates / pharmacology
Diphosphonates / therapeutic use*
Fractures, Bone / etiology
Fractures, Bone / prevention & control
Humans
Male
Osteoclasts / physiology
Pain / drug therapy
Pain / etiology
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / pathology*
RANK Ligand / physiology
Randomized Controlled Trials as Topic

Substances

Bone Density Conservation Agents
Diphosphonates
RANK Ligand